Literature DB >> 19084036

Corticotropin releasing factor enhances attentional function as assessed by the five-choice serial reaction time task in rats.

Yu Ohmura1, Taku Yamaguchi, Yukino Futami, Hiroko Togashi, Takeshi Izumi, Machiko Matsumoto, Takayuki Yoshida, Mitsuhiro Yoshioka.   

Abstract

Previous studies have shown that psychological stress affects attentional function, and corticotropin releasing factor (CRF) is closely related to stress responses. In the present study, we examined the effect of CRF on attentional function using a five-choice serial reaction time task (5-CSRTT) in rats. Accuracy in the 5-CSRTT was used as the index of attentional function. Human/rat CRF was intracerebroventricularly injected (0, 0.01, 0.1, or 1 microg/5 microl saline) 20 min before the beginning of the test trial in male Lister hooded rats that generally show high performance in the 5-CSRTT. As a result, 0.1 microg of CRF, but not other doses of CRF, increased accuracy in the 5-CSRTT. However, 0.1 microg of CRF did not affect impulsivity, motivation/appetite, perseverative tendency, or motor function. Even when Wistar rats, which generally show poor performance in the 5-CSRTT were used, 0.1 microg of CRF increased accuracy in the 5-CSRTT. However, the effect of CRF was not significantly attenuated by intracerebroventricular injection of the CRF(1) receptor antagonist antalarmin (5 microg). These results showed that CRF selectively enhances attentional function regardless of baseline attentional performance and rat strain, but this effect may be due to the pathways other than CRF(1) receptors. The present results suggest that CRF is involved in stress-related changes of attention and indicate that moderate stress, but not severe stress, may enhance attentional performance. Furthermore, these findings also indicate that the CRF-related substance could be a target for the development of an agent to improve attentional function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19084036     DOI: 10.1016/j.bbr.2008.11.025

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  15 in total

1.  Corticotropin-releasing factor in the norepinephrine nucleus, locus coeruleus, facilitates behavioral flexibility.

Authors:  Kevin Snyder; Wei-Wen Wang; Rebecca Han; Kile McFadden; Rita J Valentino
Journal:  Neuropsychopharmacology       Date:  2011-10-12       Impact factor: 7.853

Review 2.  Prefrontal cortex executive processes affected by stress in health and disease.

Authors:  Milena Girotti; Samantha M Adler; Sarah E Bulin; Elizabeth A Fucich; Denisse Paredes; David A Morilak
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-07-06       Impact factor: 5.067

3.  Lithium, but not valproic acid or carbamazepine, suppresses impulsive-like action in rats.

Authors:  Yu Ohmura; Iku Tsutsui-Kimura; Haruko Kumamoto; Masabumi Minami; Takeshi Izumi; Taku Yamaguchi; Takayuki Yoshida; Mitsuhiro Yoshioka
Journal:  Psychopharmacology (Berl)       Date:  2011-09-21       Impact factor: 4.530

4.  Striatal Cholinergic Interneurons Are a Novel Target of Corticotropin Releasing Factor.

Authors:  Julia C Lemos; Jung Hoon Shin; Veronica A Alvarez
Journal:  J Neurosci       Date:  2019-05-20       Impact factor: 6.167

5.  Nicotine provokes impulsive-like action by stimulating alpha4beta2 nicotinic acetylcholine receptors in the infralimbic, but not in the prelimbic cortex.

Authors:  Iku Tsutsui-Kimura; Yu Ohmura; Takeshi Izumi; Taku Yamaguchi; Takayuki Yoshida; Mitsuhiro Yoshioka
Journal:  Psychopharmacology (Berl)       Date:  2010-03-19       Impact factor: 4.530

6.  Milnacipran enhances the control of impulsive action by activating D₁-like receptors in the infralimbic cortex.

Authors:  Iku Tsutsui-Kimura; Yu Ohmura; Takeshi Izumi; Haruko Kumamoto; Taku Yamaguchi; Takayuki Yoshida; Mitsuhiro Yoshioka
Journal:  Psychopharmacology (Berl)       Date:  2012-08-15       Impact factor: 4.530

Review 7.  Stress-induced impairments in prefrontal-mediated behaviors and the role of the N-methyl-D-aspartate receptor.

Authors:  C Graybeal; C Kiselycznyk; A Holmes
Journal:  Neuroscience       Date:  2012-02-28       Impact factor: 3.590

Review 8.  Cognitive disruptions in stress-related psychiatric disorders: A role for corticotropin releasing factor (CRF).

Authors:  Debra A Bangasser; Yushi Kawasumi
Journal:  Horm Behav       Date:  2015-04-14       Impact factor: 3.587

9.  Corticotropin-releasing factor (CRF)-induced disruption of attention in rats is blocked by the κ-opioid receptor antagonist JDTic.

Authors:  Ashlee Van't Veer; Jessica M Yano; F Ivy Carroll; Bruce M Cohen; William A Carlezon
Journal:  Neuropsychopharmacology       Date:  2012-09-05       Impact factor: 7.853

Review 10.  Convergent pharmacological mechanisms in impulsivity and addiction: insights from rodent models.

Authors:  B Jupp; J W Dalley
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.